One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique

Maria Barra & Rebecca Richards-Kortum · 2025-08-07

3Citations

Abstract

Human papillomavirus (HPV) is responsible for nearly all cases of cervical cancer. Affordable point-of-care DNA testing is needed for cervical cancer screening in low- and middle-income countries, where most cervical cancer cases occur. HPV DNA testing typically requires complex lab infrastructure and trained personnel. In this work, we develop a loop-mediated isothermal amplification (LAMP)-based HPV DNA test, which targets three of the most oncogenic HPV types (HPV16, HPV18, HPV45) and a cellular control and achieves analytical sensitivity comparable to gold standard methods. Our extraction-free sample preparation strategy permits adding sample lysate directly to the LAMP reaction. We utilize a low-cost benchtop heater/fluorimeter, delivering results in less than one hour. We analytically evaluate our assay with clinical samples in Houston, Texas (n = 38) and Maputo, Mozambique (n = 191). Results show 100% and 93% concordance, respectively, with a reference test widely used in low-resource settings. This sensitive and specific four-step assay can potentially expand cervical cancer screening in resource-limited settings.

TL;DR

A loop-mediated isothermal amplification (LAMP)-based HPV DNA test, which targets three of the most oncogenic HPV types and a cellular control and achieves analytical sensitivity comparable to gold standard methods is developed.

AI-generated by Semantic Scholar

Institutions
Funding
UT | University of Texas MD Anderson Cancer Center (MD Anderson) Grant 128997Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in MozambiqueTechnology CoreTechnology CoreCancer Center Support GrantSample-to-answer HPV DNA nucleic acid test for cervical cancer screening in MozambiqueCancer Center Support Grant

NCI NIH HHS

U01 CA292741

U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)

U54EB034652

NIBIB NIH HHS

U54 EB034652

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

P30CA016672

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

U01CA292741

NCI NIH HHS

P30 CA016672

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U01CA292741

U.S. Department of Health & Human Services | NIH | National Cancer Institute

P30CA016672

U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering

U54EB034652